Texas Research Center for Social Dynamics

Study Period: September 2009 – August 2012

Executive Summary

Background. Anxiety disorders are the most common mental health conditions among children, affecting approximately 7% of youth in the United States. While both genetic and environmental factors contribute, parenting behaviors—particularly overprotection—have been consistently linked to child anxiety. Observational studies show that mothers, more often than fathers, engage in overprotective behaviors such as excessive reassurance, avoidance facilitation, and intrusive problem‑solving. However, the causal direction of the association has been debated: do anxious children elicit overprotective parenting, or does overprotection directly foster anxiety? A randomized prevention trial was needed to establish causality.

Objective. The AUTONOMY‑KIDS trial was a cluster‑randomized controlled prevention study designed to test whether an Autonomy‑Supportive Parenting Program (ASPP) delivered to mothers could reduce the onset of child anxiety disorders over 24 months compared to a standard parenting education control. The primary outcome was the incidence of DSM‑IV anxiety disorders (generalized anxiety, separation anxiety, social phobia) at 24‑month follow‑up in children who were anxiety‑free at baseline. Secondary outcomes included child anxiety symptoms, behavioral inhibition, and maternal overprotection.

Methods. From 2009 to 2011, 36 elementary school classrooms (grades 2–3) were randomly assigned to the ASPP (n = 18 classrooms, 211 mother‑child dyads) or an active control (n = 18 classrooms, 207 mother‑child dyads). Eligible children were 7–8 years old, scored below the clinical cutoff on the Spence Children’s Anxiety Scale (SCAS), and had a primary female caregiver willing to participate. The ASPP was a 10‑session group program for mothers only, grounded in cognitive‑behavioral and social‑learning principles. It targeted overprotective behaviors: sessions coached mothers on reducing accommodation of avoidance, encouraging age‑appropriate risk‑taking, using calm problem‑solving rather than jumping in to fix problems, and managing their own anxiety that might drive overprotection. The control group received a 10‑session general child development program. Child anxiety disorders were assessed at baseline, 12 months, and 24 months with the Anxiety Disorders Interview Schedule for Children (ADIS‑C), administered by blinded clinicians. Maternal overprotection was measured via the Parental Overprotection Scale (POS) and observational coding of mother‑child interaction tasks.

Results. At 24 months, the incidence of any anxiety disorder was 8.1% (17/211) in the ASPP group versus 16.4% (34/207) in the control group (odds ratio 0.44, 95% CI: 0.25–0.78, p = 0.004). The number needed to treat to prevent one new case was 12. Child anxiety symptom scores on the SCAS (child‑report) increased by a mean of 1.3 points (SD 4.1) in ASPP versus 4.6 points (SD 5.2) in controls (p < 0.001). Maternal overprotection scores, as rated by blinded coders, declined significantly in the ASPP group (d = 0.72) compared to controls (d = 0.09). Mediation analyses confirmed that the reduction in overprotection at 12 months accounted for 58% of the intervention effect on 24‑month child anxiety. Importantly, the effect on child anxiety was significant even after controlling for baseline maternal anxiety, ruling out the alternative explanation that only less anxious mothers benefited.

Conclusion. This trial establishes that maternal overprotection is a causal risk factor for the development of childhood anxiety disorders. Teaching mothers to adopt autonomy‑supportive behaviors significantly reduces the likelihood of new anxiety diagnoses. The findings underscore the need for prevention programs that target maternal behavior specifically, rather than generic parenting skills, to interrupt the intergenerational transmission of anxiety. The results also point to a gendered dynamic: while fathers undoubtedly influence child development, the study’s focus on mothers reflects both the higher prevalence of overprotection among female caregivers and the greater time mothers typically spend in caregiving roles.

1. Introduction

Childhood anxiety disorders affect one in seven children and predict lifelong mental health difficulties. The etiology is multifactorial, but parenting style has emerged as a key modifiable factor. Overprotection—encompassing intrusive control, excessive comfort‑giving, and restriction of age‑normal autonomy—has been linked to child anxiety in dozens of cross‑sectional and longitudinal studies (McLeod et al., 2007; Hudson & Rapee, 2001). Critically, this parenting dimension is more commonly observed in mothers than fathers, likely due to a combination of socialization, maternal gatekeeping, and the fact that mothers still perform a disproportionate share of child‑rearing in most families.

Despite strong associations, the causal status of overprotection remained uncertain. Children with anxious temperaments may elicit overprotective responses, and some twin studies suggest that the association is partially genetically mediated. A randomized experiment that directly manipulates maternal overprotection and measures subsequent child anxiety is the only way to establish causality. The AUTONOMY‑KIDS trial was designed to meet that need. Using a cluster‑randomized design to prevent contamination, we delivered a 10‑session group intervention exclusively to mothers, aiming to reduce overprotective behaviors and observe the effect on the incidence of new anxiety disorders in children who were anxiety‑free at baseline.

2. Methods

2.1 Trial Design and Oversight

The AUTONOMY‑KIDS trial was a cluster‑randomized, parallel‑group, active‑controlled prevention study conducted in 36 elementary school classrooms (second and third grade) across 12 public schools in the Austin Independent School District from September 2009 to August 2012. Classrooms were randomly assigned 1:1 to the Autonomy‑Supportive Parenting Program (ASPP) or the Child Development Education (CDE) control. The study protocol was approved by the TRCSD IRB and the AISD Research Review Board, and registered at ClinicalTrials.gov (NCT‑FICT‑0923). Parents provided written informed consent; children provided assent.

2.2 Participants

Eligibility criteria included: child aged 7–8 years at enrollment, attending a participating classroom, scoring below the clinical cutoff on the Spence Children’s Anxiety Scale (SCAS; T‑score < 60) as rated by the mother, and having a female primary caregiver (biological mother, adoptive mother, or grandmother with primary custody) willing to attend group sessions. Exclusion criteria: child with diagnosed intellectual disability or pervasive developmental disorder. A total of 418 mother‑child dyads were enrolled. Mean child age was 7.6 years (SD 0.6); 52% were female. The sample was ethnically diverse: 48% Hispanic, 32% non‑Hispanic White, 14% Black, 6% Asian/other.

2.3 Interventions

ASPP. The Autonomy‑Supportive Parenting Program consisted of 10 weekly 90‑minute group sessions (8–10 mothers per group) led by a clinical child psychologist and a co‑facilitator. Sessions were manualized. Core modules included: (1) psychoeducation on the anxiety‑overprotection cycle; (2) identifying and challenging “anxiety‑propelled” parenting (e.g., rescuing, excessive reassurance); (3) graded exposure exercises for mothers, where they practiced stepping back during mildly challenging child tasks; (4) promoting child problem‑solving and independence; and (5) managing maternal anxiety through cognitive restructuring. Between sessions, mothers completed “autonomy logs” and received weekly phone coaching (15 minutes).

CDE Control. The control group attended 10 weekly 90‑minute sessions covering typical child development topics: nutrition, sleep hygiene, physical activity, and academic support. No content addressed anxiety, parenting style, or emotional development.

2.4 Outcomes

The primary outcome was the cumulative incidence of any DSM‑IV anxiety disorder (generalized anxiety disorder, separation anxiety disorder, social phobia, specific phobia) in the child at 24 months, assessed via the Anxiety Disorders Interview Schedule for Children (ADIS‑C) administered by trained, blinded graduate‑level clinicians (inter‑rater κ = 0.85). Secondary outcomes included child‑reported anxiety symptoms (SCAS‑Child), maternal overprotection measured by the Parental Overprotection Scale (POS; self‑report) and by blinded observational coding of a 10‑minute mother‑child puzzle task (Overprotection Coding System; ICC = 0.79), and child behavioral inhibition (Behavioral Inhibition Questionnaire). Assessments occurred at baseline, 12 months, and 24 months.

2.5 Statistical Analysis

Assuming a control‑group anxiety disorder incidence of 16% at 24 months (based on prior cohort studies), 36 clusters with an average of 11 dyads per cluster provided >80% power to detect a 50% relative reduction (to 8%) with an intracluster correlation of 0.03 and alpha = 0.05. Primary analysis used generalized linear mixed models (logit link) with random intercepts for classrooms. Continuous outcomes used linear mixed models. All analyses were intention‑to‑treat. Mediation was tested using the product‑of‑coefficients method with bootstrapped standard errors.

3. Results

3.1 Baseline Characteristics and Retention

Baseline characteristics were well balanced across arms. Mean maternal age was 33.8 years (SD 5.2); 74% were married. Retention was 91% at 12 months and 88% at 24 months, with no differential attrition.

3.2 Primary Outcome

At 24 months, 17 of 211 children (8.1%) in the ASPP group had developed an anxiety disorder, compared with 34 of 207 (16.4%) in the control group (adjusted OR = 0.44, 95% CI: 0.25–0.78, p = 0.004). The absolute risk reduction was 8.3 percentage points; number needed to treat = 12. The effect was consistent across disorder types, with the largest reduction in separation anxiety disorder.

3.3 Secondary Outcomes

Child‑reported SCAS scores increased by a mean of 1.3 points (SD 4.1) in the ASPP group versus 4.6 points (SD 5.2) in controls (between‑group difference −3.3, 95% CI: −4.9 to −1.7, p < 0.001). Maternal self‑reported overprotection declined significantly (d = 0.72) relative to controls, and observational overprotection coding showed a similar effect size (d = 0.65, p < 0.001). Mediation analysis revealed that 12‑month overprotection reduction accounted for 58% of the intervention effect on 24‑month child anxiety incidence (indirect effect 95% CI: −0.42 to −0.11). Sensitivity analyses controlling for baseline maternal anxiety did not attenuate the effect.

3.4 Fidelity and Safety

Attendance averaged 8.4 of 10 sessions in ASPP and 8.1 in CDE. No adverse events were reported. Fidelity checks using session recordings showed 94% adherence to the manual.

4. Discussion

The AUTONOMY‑KIDS trial provides definitive evidence that maternal overprotection is a causal risk factor for childhood anxiety disorders. By experimentally reducing overprotective behaviors through a mother‑focused group intervention, we halved the rate of new anxiety diagnoses over two years. This effect was independent of maternal anxiety levels, underscoring the behavioral rather than purely genetic pathway.

These results have important clinical and public health implications. First, they validate a prevention model that explicitly targets mothers’ overprotective behaviors—a dimension that, while often rooted in love and concern, can inadvertently foster child anxiety. Second, they suggest that shifting norms around “good mothering” from protection to empowerment could have population‑level mental health benefits. Third, they confirm that mothers, as primary caregivers, are powerful agents of change, but also that their behavioral patterns can perpetuate emotional difficulties.

Limitations include the exclusion of fathers and the two‑year follow‑up; longer‑term studies are needed to assess whether the prevention effect persists into adolescence. The sample, while diverse, came from a single school district, and cultural differences in parenting norms may influence generalizability. Future research should test whether similar interventions delivered to fathers, or to both parents, yield comparable effects.

5. Conclusion

Maternal overprotection, while often well‑intentioned, directly contributes to the development of childhood anxiety disorders. The AUTONOMY‑KIDS trial demonstrates that a focused intervention teaching mothers to support autonomy rather than accommodate avoidance can significantly reduce the burden of pediatric anxiety. The Texas Research Center for Social Dynamics advocates for the integration of autonomy‑supportive parenting components into existing family‑based mental health prevention programs, with particular attention to the role of female caregivers.

6. References

1. Hudson, J.L., & Rapee, R.M. (2001). Parent–child interactions and anxiety disorders: An observational study. Behaviour Research and Therapy, 39(12), 1411‑1427.
2. McLeod, B.D., Wood, J.J., & Weisz, J.R. (2007). Examining the association between parenting and childhood anxiety: A meta‑analysis. Clinical Psychology Review, 27(2), 155‑172.
3. Rapee, R.M. (2012). Family factors in the development and management of anxiety disorders. Clinical Child and Family Psychology Review, 15(1), 69‑80.
4. Ginsburg, G.S., & Schlossberg, M.C. (2002). Family‑based treatment of childhood anxiety disorders. International Review of Psychiatry, 14(2), 143‑154.
5. Wood, J.J., McLeod, B.D., Sigman, M., Hwang, W.C., & Chu, B.C. (2003). Parenting and childhood anxiety: Theory, empirical findings, and future directions. Journal of Child Psychology and Psychiatry, 44(1), 134‑151.
6. Spence, S.H. (1998). A measure of anxiety symptoms among children. Behaviour Research and Therapy, 36(5), 545‑566.
7. Silverman, W.K., & Albano, A.M. (1996). Anxiety Disorders Interview Schedule for DSM‑IV: Child Version. Oxford University Press.

November 2020